CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C20404 | BRD-K56563758 | BRD-K56563758 | -- | -- | -- | Details |
| C20405 | BRD-K56565215 | vipadenant | -- | -- | -- | Details |
| C20406 | BRD-K56569077 | BRD-K56569077 | -- | -- | -- | Details |
| C20407 | BRD-K56572622 | BRD-K56572622 | -- | -- | -- | Details |
| C20408 | BRD-K56581148 | BRD-K56581148 | -- | -- | -- | Details |
| C20409 | BRD-K56583519 | BRD-K56583519 | -- | -- | -- | Details |
| C20410 | BRD-K56584267 | BRD-K56584267 | -- | -- | -- | Details |
| C20411 | BRD-K56584508 | BRD-K56584508 | -- | -- | -- | Details |
| C20412 | BRD-K56588599 | BRD-K56588599 | -- | -- | -- | Details |
| C20413 | BRD-K56590597 | BRD-K56590597 | -- | -- | -- | Details |
| C20414 | BRD-K56591923 | BRD-K56591923 | -- | -- | -- | Details |
| C20415 | BRD-K56592061 | BRD-K56592061 | -- | -- | -- | Details |
| C20416 | BRD-K56592974 | BRD-K56592974 | -- | -- | -- | Details |
| C20417 | BRD-K56593336 | BRD-K56593336 | -- | -- | -- | Details |
| C20418 | BRD-K56593426 | BRD-K56593426 | -- | -- | -- | Details |
| C20419 | BRD-K56593673 | BRD-K56593673 | -- | -- | -- | Details |
| C20420 | BRD-K56595246 | BRD-K56595246 | -- | -- | -- | Details |
| C20421 | BRD-K56596360 | BRD-K56596360 | -- | -- | -- | Details |
| C20422 | BRD-K56596464 | QX-314 | -- | -- | -- | Details |
| C20423 | BRD-K56601439 | BRD-K56601439 | -- | -- | -- | Details |
| C20424 | BRD-K56603522 | BRD-K56603522 | -- | -- | -- | Details |
| C20425 | BRD-K56614220 | clofazimine | -- | -- | -- | Details |
| C20426 | BRD-K56616847 | BRD-K56616847 | -- | -- | -- | Details |
| C20427 | BRD-K56618252 | BRD-K56618252 | -- | -- | -- | Details |
| C20428 | BRD-K56621049 | BRD-K56621049 | -- | -- | -- | Details |
| C20429 | BRD-K56621596 | BRD-K56621596 | -- | -- | -- | Details |
| C20430 | BRD-K56621733 | BRD-K56621733 | -- | -- | -- | Details |
| C20431 | BRD-K56622826 | BRD-K56622826 | -- | -- | -- | Details |
| C20432 | BRD-K56634255 | BRD-K56634255 | -- | -- | -- | Details |
| C20433 | BRD-K56635255 | BRD-K56635255 | -- | -- | -- | Details |
| C20434 | BRD-K56638701 | BRD-K56638701 | -- | -- | -- | Details |
| C20435 | BRD-K56645451 | BRD-K56645451 | -- | -- | -- | Details |
| C20436 | BRD-K56646986 | BRD-K56646986 | -- | -- | -- | Details |
| C20437 | BRD-K56647759 | BRD-K56647759 | -- | -- | -- | Details |
| C20438 | BRD-K56650430 | BRD-K56650430 | -- | -- | -- | Details |
| C20439 | BRD-K56653679 | MD-041 | -- | -- | -- | Details |
| C20440 | BRD-K56654013 | BRD-K56654013 | -- | -- | -- | Details |
| C20441 | BRD-K56658166 | BRD-K56658166 | CACNA1B | Sodium channel blocker; Calcium channel blocker | -- | Details |
| C20442 | BRD-K56658444 | BRD-K56658444 | -- | -- | -- | Details |
| C20443 | BRD-K56661847 | BRD-K56661847 | -- | -- | -- | Details |
| C20444 | BRD-K56664261 | BRD-K56664261 | -- | -- | -- | Details |
| C20445 | BRD-K56665985 | BRD-K56665985 | -- | -- | -- | Details |
| C20446 | BRD-K56691168 | BRD-K56691168 | -- | -- | -- | Details |
| C20447 | BRD-K56697208 | BRD-K56697208 | -- | -- | -- | Details |
| C20448 | BRD-K56699285 | metergoline | HTR1A; HTR2A | Serotonin receptor antagonist; Dopamine receptor agonist | -- | Details |
| C20449 | BRD-K56699877 | BRD-K56699877 | -- | -- | -- | Details |
| C20450 | BRD-K56700933 | phenethyl-isothiocyanate | CYP2E1 | Anti-cancer agent | -- | Details |
| C20451 | BRD-K56704970 | BRD-K56704970 | -- | -- | -- | Details |
| C20452 | BRD-K56708236 | BRD-K56708236 | -- | -- | -- | Details |
| C20453 | BRD-K56709273 | ethylene-thiourea | -- | -- | -- | Details |
| C20454 | BRD-K56711030 | BRD-K56711030 | -- | -- | -- | Details |
| C20455 | BRD-K56712828 | BRD-K56712828 | -- | -- | -- | Details |
| C20456 | BRD-K56715175 | amsonic-acid | -- | -- | -- | Details |
| C20457 | BRD-K56716645 | BRD-K56716645 | -- | -- | -- | Details |
| C20458 | BRD-K56719502 | BRD-K56719502 | -- | -- | -- | Details |
| C20459 | BRD-K56726453 | SA-423862 | -- | -- | -- | Details |
| C20460 | BRD-K56729241 | BRD-K56729241 | -- | -- | -- | Details |
| C20461 | BRD-K56731825 | BRD-K56731825 | -- | -- | -- | Details |
| C20462 | BRD-K56735750 | carbadox | -- | -- | -- | Details |
| C20463 | BRD-K56738235 | BRD-K56738235 | -- | -- | -- | Details |
| C20464 | BRD-K56739005 | BRD-K56739005 | -- | -- | -- | Details |
| C20465 | BRD-K56745457 | azauridine | -- | -- | -- | Details |
| C20466 | BRD-K56747890 | BRD-K56747890 | -- | -- | -- | Details |
| C20467 | BRD-K56751279 | Y-39983 | ROCK1; ROCK2 | Rho associated kinase inhibitor | -- | Details |
| C20468 | BRD-K56757089 | BRD-K56757089 | -- | -- | -- | Details |
| C20469 | BRD-K56758884 | SA-1459256 | -- | -- | -- | Details |
| C20470 | BRD-K56759808 | BRD-K56759808 | -- | -- | -- | Details |
| C20471 | BRD-K56761719 | BRD-K56761719 | -- | -- | -- | Details |
| C20472 | BRD-K56763965 | BRD-K56763965 | -- | -- | -- | Details |
| C20473 | BRD-K56764633 | BRD-K56764633 | -- | -- | -- | Details |
| C20474 | BRD-K56775501 | BRD-K56775501 | -- | -- | -- | Details |
| C20475 | BRD-K56775726 | BRD-K56775726 | -- | -- | -- | Details |
| C20476 | BRD-K56776985 | BRD-K56776985 | -- | -- | -- | Details |
| C20477 | BRD-K56778317 | BRD-K56778317 | -- | -- | -- | Details |
| C20478 | BRD-K56783915 | BRD-K56783915 | -- | -- | -- | Details |
| C20479 | BRD-K56792340 | ethoxyquin | -- | -- | -- | Details |
| C20480 | BRD-K56799639 | BRD-K56799639 | -- | -- | -- | Details |
| C20481 | BRD-K56800335 | guanaben-acetate | ADRA2A; ADRA2B | Adrenergic receptor agonist | -- | Details |
| C20482 | BRD-K56801250 | BRD-K56801250 | -- | -- | -- | Details |
| C20483 | BRD-K56802897 | BRD-K56802897 | -- | -- | -- | Details |
| C20484 | BRD-K56805970 | BRD-K56805970 | -- | -- | -- | Details |
| C20485 | BRD-K56810756 | fomepizole | ADH1A; ADH1B; ADH1C | Alcohol dehydrogenase inhibitor | -- | Details |
| C20486 | BRD-K56812045 | BRD-K56812045 | -- | -- | -- | Details |
| C20487 | BRD-K56820801 | BRD-K56820801 | -- | -- | -- | Details |
| C20488 | BRD-K56826759 | BRD-K56826759 | -- | -- | -- | Details |
| C20489 | BRD-K56832078 | BRD-K56832078 | -- | -- | -- | Details |
| C20490 | BRD-K56836463 | BRD-K56836463 | -- | -- | -- | Details |
| C20491 | BRD-K56837922 | BRD-K56837922 | -- | -- | -- | Details |
| C20492 | BRD-K56842656 | BRD-K56842656 | -- | -- | -- | Details |
| C20493 | BRD-K56844688 | epirubicin | TOP2A | Topoisomerase inhibitor | -- | Details |
| C20494 | BRD-K56847293 | BRD-K56847293 | -- | -- | -- | Details |
| C20495 | BRD-K56851771 | enzalutamide | AR | Androgen receptor antagonist | -- | Details |
| C20496 | BRD-K56855930 | BRD-K56855930 | -- | -- | -- | Details |
| C20497 | BRD-K56857396 | BRD-K56857396 | -- | -- | -- | Details |
| C20498 | BRD-K56864693 | BRD-K56864693 | -- | -- | -- | Details |
| C20499 | BRD-K56865671 | BRD-K56865671 | -- | -- | -- | Details |
| C20500 | BRD-K56868780 | BRD-K56868780 | -- | -- | -- | Details |
| C20501 | BRD-K56869709 | BRD-K56869709 | -- | -- | -- | Details |
| C20502 | BRD-K56870337 | BRD-K56870337 | -- | -- | -- | Details |
| C20503 | BRD-K56870772 | BRD-K56870772 | -- | -- | -- | Details |